Total Payments
$3,884
2024 Payments
$295.48
Companies
42
Transactions
184
Medicare Patients
811
Medicare Billing
$91,493
Payment Breakdown by Category
Food & Beverage$2,879 (74.1%)
Consulting$700.00 (18.0%)
Education$305.26 (7.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,879 | 164 | 74.1% |
| Consulting Fee | $700.00 | 1 | 18.0% |
| Education | $305.26 | 13 | 7.9% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$3,884
178 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $784.37 | 42 | $0 (2024) |
| Boston Scientific Corporation | $700.00 | 1 | $0 (2019) |
| PFIZER INC. | $204.68 | 12 | $0 (2024) |
| Hologic, LLC | $181.22 | 14 | $0 (2021) |
| MILLICENT US INC | $163.52 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $150.97 | 6 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $113.46 | 7 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $113.39 | 8 | $0 (2020) |
| Agile Therapeutics, Inc. | $97.40 | 5 | $0 (2022) |
| CooperSurgical, Inc. | $92.72 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $295.48 | 17 | MILLICENT US INC ($131.37) |
| 2023 | $172.47 | 5 | Astellas Pharma US Inc ($84.99) |
| 2022 | $337.12 | 19 | PFIZER INC. ($79.13) |
| 2021 | $425.85 | 25 | Medtronic, Inc. ($81.77) |
| 2020 | $427.03 | 23 | Amgen Inc. ($144.23) |
| 2019 | $1,201 | 28 | Boston Scientific Corporation ($700.00) |
| 2018 | $525.69 | 36 | Amgen Inc. ($153.63) |
| 2017 | $499.32 | 31 | Amgen Inc. ($174.73) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/21/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $5.62 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: HORMONE THERAPY | ||||||
| 10/22/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $16.81 | General |
| 10/17/2024 | MILLICENT US INC | — | Education | In-kind items and services | $40.05 | General |
| 10/16/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/14/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: HORMONE THERAPY | ||||||
| 09/16/2024 | MILLICENT US INC | — | Education | In-kind items and services | $26.70 | General |
| 09/16/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 07/16/2024 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Ablation System | ||||||
| 06/19/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Endocrinology | ||||||
| 06/17/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 05/28/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: WOMENS HEALTH | ||||||
| 03/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Bone Health | ||||||
| 02/13/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: WOMENS HEALTH | ||||||
| 2024 | Unified Women's Healthcare, LP | — | — | — | $0.00 | Ownership |
| 06/14/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Endocrinology | ||||||
| 05/30/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $52.00 | General |
| 05/24/2023 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 03/30/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 2023 | Unified Women's Healthcare, LP | — | — | — | $0.00 | Ownership |
| 09/29/2022 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: WOMENS HEALTH | ||||||
| 08/01/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Neuromodulation | ||||||
| 07/30/2022 | PFIZER INC. | PREMARIN (Drug), PREMARIN, ESTRING | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 222 | 228 | $14,520 | $9,867 |
| 2022 | 5 | 240 | 245 | $25,335 | $12,205 |
| 2021 | 5 | 152 | 807 | $29,557 | $17,038 |
| 2020 | 5 | 197 | 3,056 | $124,780 | $52,384 |
Total Patients
811
Total Services
4,336
Medicare Billing
$91,493
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 161 | 161 | $8,855 | $6,273 | 70.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 36 | $3,960 | $2,258 | 57.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 31 | 31 | $1,705 | $1,336 | 78.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 142 | 142 | $7,810 | $5,662 | 72.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 30 | $3,300 | $1,978 | 59.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 44 | 44 | $2,420 | $1,933 | 79.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 14 | 15 | $6,345 | $1,483 | 23.4% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 13 | 14 | $5,460 | $1,149 | 21.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 660 | $19,800 | $10,038 | 50.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 92 | 92 | $5,005 | $3,697 | 73.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 23 | $2,512 | $1,628 | 64.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 21 | 21 | $1,140 | $936.18 | 82.1% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 11 | 11 | $1,100 | $738.10 | 67.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 35 | 2,880 | $110,400 | $44,090 | 39.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 96 | 96 | $6,890 | $3,957 | 57.4% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2020 | 34 | 46 | $5,100 | $2,790 | 54.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 21 | 21 | $1,050 | $929.52 | 88.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $1,340 | $616.56 | 46.0% |
About Dr. Gregory Demeo, D.O
Dr. Gregory Demeo, D.O is a Obstetrics & Gynecology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497712657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Demeo, D.O has received a total of $3,884 in payments from pharmaceutical and medical device companies, with $295.48 received in 2024. These payments were reported across 184 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,879).
As a Medicare-enrolled provider, Demeo has provided services to 811 Medicare beneficiaries, totaling 4,336 services with total Medicare billing of $91,493. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Newark, DE
- Active Since 04/28/2006
- Last Updated 04/02/2021
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1497712657
Products in Payments
- SYMPHION (Device) $700.00
- EVENITY (Biological) $431.70
- Prolia (Biological) $311.66
- PREMARIN (Drug) $177.93
- TruClear (Device) $160.03
- INTRAROSA (Drug) $129.09
- Kyleena (Drug) $97.80
- Twirla (Drug) $97.40
- Novasure (Device) $96.61
- Leva Pelvic Floor Trainer (Device) $82.67
- CitraNatal (Drug) $74.23
- MYFEMBREE (Drug) $73.94
- LO LOESTRIN FE (Drug) $68.40
- MYRBETRIQ (Drug) $65.98
- MD cobas Instruments and Reagents (Device) $63.14
- Phexxi (Drug) $61.58
- INJECTAFER (Drug) $61.56
- Balcoltra (Drug) $59.34
- Paragard T 380A (Drug) $40.55
- IMVEXXY (Drug) $40.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Newark
Debra Davis, M.d, M.D
Obstetrics & Gynecology — Payments: $48,612
Obstetrics & Gynecology $48,612
Mr. Richard Derman, Md, MD
Obstetrics & Gynecology — Payments: $14,477
Obstetrics & Gynecology $14,477
Dr. Edsel Antonio, Do, DO
Obstetrics & Gynecology — Payments: $8,135
Obstetrics & Gynecology $8,135
Howard Goldstein, Do, DO
Obstetrics & Gynecology — Payments: $6,334
Obstetrics & Gynecology $6,334
Gordon Ostrum, M.d, M.D
Obstetrics & Gynecology — Payments: $5,382
Obstetrics & Gynecology $5,382
Dr. Joel Ross, M.d, M.D
Obstetrics & Gynecology — Payments: $4,796
Obstetrics & Gynecology $4,796